We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. GCA diagnoses made via temporal artery ultrasound were ...

Please provide your email address to receive an email when new articles are posted on . KIAWAH ISLAND, S.C. — Temporal artery ultrasound and EULAR score are reliable means for diagnosing giant cell ...

Temporal artery ultrasound alone was sufficient to accurately diagnose giant cell arteritis (GCA) in over half of patients in a new prospective study. The findings provide further evidence that ...

SHREVEPORT, La. - Giant cell arteritis, also known as temporal arteritis, is a less common condition where people get inflammation of the arteries that go to the head and neck. Symptoms include, head ...

Positive findings with color Doppler ultrasound were enough to diagnose giant cell arteritis (GCA) accurately without need for confirmation with temporal artery biopsy (TAB), a prospective study ...

Have your consultants ever seen a case of temporal arteritis present with an isolated C5 radiculopathy and peripheral (lower motor neuron) facial-nerve palsy one month prior to ocular findings?

For most of us, the phrase "stroke of the eye" sounds like a metaphor. But for UK HealthCare's Jagannadha "Jay" Avasarala, M.D., Ph.D., it's a literal and urgent diagnosis—one that could mean the ...

A new point-of-care prediction tool that uses clinical and ultrasonography findings has good accuracy for identifying giant cell arteritis among patients seen in fast-track clinics. Investigators ...

Viral, bacterial, and atherosclerotic diseases are among the potential environmental causes of GCA and PMR. Possible causes include parainfluenza virus type 1, Mycoplasma pneumoniae, parvovirus B19 ...

CHICAGO -- Treatment of giant cell arteritis (GCA) with the oral drug upadacitinib (Rinvoq) was durably effective when continued for 2 years, results from a phase III trial extension indicated. Some ...

Less than a year ago, AbbVie's star immunology drug Rinvoq picked up its seventh FDA approval when the agency endorsed it in Crohn's disease. After a new positive pivotal trial, the drug could be ...